Synvista Therapeutics, Inc. 4
4 · Synvista Therapeutics, Inc. · Filed Sep 17, 2007
Insider Transaction Report
Form 4
Berkowitz Noah
DirectorPresident & CEO10% Owner
Transactions
- Disposition to Issuer
Common Stock
2007-09-13$4.05/sh−131$531→ 177,516 total - Disposition to Issuer
Common Stock
2007-09-13$3.55/sh−1,517$5,385→ 167,503 total - Disposition to Issuer
Common Stock
2007-09-13$3.80/sh−923$3,507→ 174,556 total - Disposition to Issuer
Common Stock
2007-09-13$3.70/sh−1,649$6,101→ 171,790 total - Disposition to Issuer
Common Stock
2007-09-13$3.55/sh−1,583$5,620→ 165,920 total - Disposition to Issuer
Common Stock
2007-09-13$3.86/sh−65$251→ 177,451 total - Disposition to Issuer
Common Stock
2007-09-13$3.60/sh−2,573$9,263→ 169,217 total - Disposition to Issuer
Common Stock
2007-09-13$4.31/sh−197$849→ 178,108 total - Disposition to Issuer
Common Stock
2007-09-13$3.47/sh−319$1,107→ 163,152 total - Disposition to Issuer
Common Stock
2007-09-13$4.31/sh−329$1,418→ 178,305 total - Disposition to Issuer
Common Stock
2007-09-13$4.25/sh−461$1,959→ 177,647 total - Disposition to Issuer
Common Stock
2007-09-13$3.86/sh−1,185$4,574→ 176,004 total - Disposition to Issuer
Common Stock
2007-09-13$3.46/sh−659$2,280→ 165,261 total - Disposition to Issuer
Common Stock
2007-09-13$3.86/sh−263$1,015→ 173,899 total - Disposition to Issuer
Common Stock
2007-09-13$3.50/sh−1,329$4,652→ 163,471 total - Disposition to Issuer
Common Stock
2007-09-13$3.86/sh−395$1,525→ 175,544 total
Footnotes (1)
- [F1]Transactions completed pursuant to a 10B5-1 plan.